New gel shows promise for diabetic foot wounds

NCT ID NCT06111183

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new gel called AUP1602-C on 64 people with diabetes who had foot ulcers that were not healing. The gel was applied directly to the wound and covered with a dressing. The goal was to see if it is safe and helps wounds close faster compared to a placebo gel. The trial is now complete, and results will show whether this treatment could become a new option for diabetic foot care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AUP1602-C (a biological gel applied to wounds)
What this could lead to
If successful, this could provide a new treatment option to help heal stubborn diabetic foot ulcers, reducing the risk of infection and amputation.
What could go wrong
This is an early Phase 2 trial with only 64 participants, so results may not apply to everyone. The treatment may not work better than standard care or placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AOU Pisana - Ospedale S. Chiara

    Pisa, Italy

  • Azienda Ospedaliero-Universitaria Careggi

    Florence, Italy

  • Hauärztliche und Diabetologische Praxis

    Pirna, Germany

  • Institut für Diabetesforschung Muenster GmbH

    Münster, Germany

  • Lecran Centrum Opieki Nad Ranami

    Wroclaw, Poland

  • Med-Polonia SP. Z O.O.

    Poznan, Poland

  • Mikomed

    Lodz, Poland

  • Ospedale S. Jacopo Pistoia, Diabetologia e Diabetic foot unit Aziendale

    Pistoia, Italy

  • Ospedale San Donato

    Arezzo, Italy

  • PODOS Klinika Leczenia Ran Podema sp. z o.o.

    Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.